Most cited papers from Tosei General Hospital
What are the most cited papers from Tosei General Hospital?
The most cited paper from Tosei General Hospital is "Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis" (Luca Richeldi et al., 2014), with 4,731 citations. Next come "Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report" (1,486) and "Idiopathic pulmonary fibrosis" (1,412).
Showing 50 of 61 papers. Every paper with more than 88 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis Luca Richeldi et al. · New England Journal of Medicine | 18 May 2014 | 4,731 |
| 2 | Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine | 14 Jun 2016 | 1,486 |
| 3 | Idiopathic pulmonary fibrosis Fernando J. Martínez, Harold R. Collard, Annie Pardo et al. · Nature Reviews Disease Primers | 19 Oct 2017 | 1,412 |
| 4 | Acute Exacerbations of Idiopathic Pulmonary Fibrosis Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine | 21 Jun 2007 | 1,139 |
| 5 | Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature | 8 Jul 2021 | 1,130 |
| 6 | Pirfenidone in idiopathic pulmonary fibrosis H. Taniguchi, Masahito Ebina, Yasuhiro Kondoh et al. · European Respiratory Journal | 8 Dec 2009 | 955 |
| 7 | Pirfenidone in idiopathic pulmonary fibrosis: Figure 1– J. Swigris, D. Fairclough · European Respiratory Journal | 31 Aug 2010 | 800 |
| 8 | Embryonic karyotype of abortuses in relation to the number of previous miscarriages Mayumi Ogasawara, Koji Aoki, Setsuo Okada et al. · Fertility and Sterility | Feb 2000 | 610 |
| 9 | Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Enyu Imai et al. · Clinical and Experimental Nephrology | 23 Mar 2007 | 544 |
| 10 | Acute Exacerbation in Idiopathic Pulmonary Fibrosis Yasuhiro Kondoh, Hiroyuki Taniguchi, Yoshinori Kawabata et al. · CHEST Journal | Jun 1993 | 464 |
| 11 | Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study Simon L. F. Walsh et al. · The Lancet Respiratory Medicine | 11 May 2016 | 460 |
| 12 | Computed Tomography Findings in Pathological Usual Interstitial Pneumonia Hiromitsu Sumikawa, Takeshi Johkoh, Thomas Vail Colby et al. · American Journal of Respiratory and Critical Care Medicine | Nov 2007 | 356 |
| 13 | Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Osamu Nishiyama, Yasuhiro Kondoh, Tomoki Kimura et al. · Respirology | 11 Dec 2007 | 315 |
| 14 | Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient Enyu Imai et al. · Clinical and Experimental Nephrology | Jun 2007 | 298 |
| 15 | Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia Yuichiro Shindo et al. · American Journal of Respiratory and Critical Care Medicine | 15 Jul 2013 | 296 |
| 16 | Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Sharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh et al. · American Journal of Respiratory and Critical Care Medicine | 26 Feb 2011 | 290 |
| 17 | Palliative care in interstitial lung disease: living well Michael Kreuter et al. · The Lancet Respiratory Medicine | 13 Oct 2017 | 271 |
| 18 | A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis Taisei Mushiroda, Sukanya Wattanapokayakit, Atsushi Takahashi et al. · Journal of Medical Genetics | Oct 2008 | 248 |
| 19 | A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · European Respiratory Journal | 22 Apr 2010 | 248 |
| 20 | A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19 Yohei Doi et al. · Antimicrobial Agents and Chemotherapy | 22 Sep 2020 | 238 |
| 21 | Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis Motohiro Kimura, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · Respiration | 19 Dec 2012 | 222 |
| 22 | Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma et al. · European Respiratory Journal | 10 Dec 2014 | 218 |
| 23 | Quadriceps Weakness Is Related to Exercise Capacity in Idiopathic Pulmonary Fibrosis Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · CHEST Journal | Jun 2005 | 201 |
| 24 | Acute exacerbations of fibrotic interstitial lung diseases Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown et al. · Respirology | 19 Aug 2019 | 181 |
| 25 | Acute exacerbation of interstitial pneumonia following surgical lung biopsy Yasuhiro Kondoh, Hiroyuki Taniguchi, Masanori Kitaichi et al. · Respiratory Medicine | 5 Apr 2006 | 173 |
| 26 | Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Yasuhiro Kondoh, Hiroyuki Taniguchi, T Katsuta et al. · PubMed | Jul 2010 | 169 |
| 27 | Acute Interstitial Pneumonia: Thin-Section CT Findings in 36 Patients Takeshi Johkoh, Néstor L. Müller, Hiroyuki Taniguchi et al. · Radiology | Jun 1999 | 160 |
| 28 | Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF) Shigeki Saito, Ala L. Alkhatib, Jay K. Kolls et al. · Journal of Thoracic Disease | Sep 2019 | 158 |
| 29 | Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis Sakae A. Homma, Arata Azuma, Hiroyuki Taniguchi et al. · Respirology | 18 Jan 2012 | 146 |
| 30 | Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · Respiratory Medicine | 26 Oct 2004 | 145 |
| 31 | Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma* H Miyatake, Fumio Taki, Hiroyuki Taniguchi et al. · CHEST Journal | Mar 1991 | 144 |
| 32 | Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis Harold R. Collard, Luca Richeldi, Dong Soon Kim et al. · European Respiratory Journal | May 2017 | 141 |
| 33 | Japanese guideline for the treatment of idiopathic pulmonary fibrosis Sakae A. Homma et al. · Respiratory Investigation | Jul 2018 | 135 |
| 34 | Endolymphatic hydrops and blood–labyrinth barrier in Ménière's disease Mitsuhiko Tagaya, Masahiro Yamazaki, Masaaki Teranishi et al. · Acta Oto-Laryngologica | 3 Jan 2011 | 135 |
| 35 | Adsorptive Granulocyte and Monocyte Apheresis versus Prednisolone in Patients with Corticosteroid-Dependent Moderately Severe Ulcerative Colitis Hiroyuki Hanai, Fumitoshi Watanabe, Masami Yamada et al. · Digestion | 2004 | 131 |
| 36 | Acute Exacerbation of Chronic Interstitial Pneumonia C. Isabela S. Silva, Néstor L. Müller, Kiminori Fujimoto et al. · Journal of Thoracic Imaging | Aug 2007 | 127 |
| 37 | A second update on mapping the human genetic architecture of COVID-19 The COVID-19 Host Genetics Initiative et al. · Nature | 6 Sep 2023 | 125 |
| 38 | Usual Interstitial Pneumonia and Chronic Idiopathic Interstitial Pneumonia: Analysis of CT Appearance in 92 Patients Hiromitsu Sumikawa, Takeshi Johkoh, Kazuya Ichikado et al. · Radiology | Oct 2006 | 124 |
| 39 | Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality Kiminori Fujimoto, Hiroyuki Taniguchi, Takeshi Johkoh et al. · European Radiology | 6 Aug 2011 | 123 |
| 40 | A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes Yukihiro Sato, Hiroyuki Sato, K. Naka et al. · Archives of Virology | 7 Apr 2011 | 122 |
| 41 | JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias Katsushige Ono et al. · Circulation Journal | 10 Mar 2022 | 120 |
| 42 | Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Michael Kreuter et al. · European Respiratory Journal | 14 Feb 2020 | 119 |
| 43 | Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment Arata Azuma, Yoshio Taguchi, Takashi Ogura et al. · Respiratory Research | 16 Nov 2011 | 116 |
| 44 | Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors Jun Fukihara, Koji Sakamoto, Junji Koyama et al. · Clinical Lung Cancer | Aug 2019 | 114 |
| 45 | Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Kensuke Kataoka, Hiroyuki Taniguchi, Yasuhiro Kondoh et al. · CHEST Journal | 27 Mar 2015 | 114 |
| 46 | 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease Yasuhiro Kondoh et al. · Respiratory Investigation | Oct 2021 | 112 |
| 47 | Noninvasive Ventilation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Toshiki Yokoyama, Yasuhiro Kondoh, Hiroyuki Taniguchi et al. · Internal Medicine | 2010 | 112 |
| 48 | Home monitoring in interstitial lung diseases Marlies S Wijsenbeek, Catharina C. Moor, Kerri A. Johannson et al. · The Lancet Respiratory Medicine | 4 Oct 2022 | 105 |
| 49 | The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction Yasushi Numaguchi, Takahito Sone, Kenji Okumura et al. · Circulation | 4 Jul 2006 | 105 |
| 50 | Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis Luca Richeldi, Vincent Cottin, Kevin R. Flaherty et al. · Respiratory Medicine | 28 Apr 2014 | 105 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.